CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 96  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0500
LYS 10.0123
GLU 20.0038
LEU 30.0089
ARG 40.0236
CYS 50.0101
GLN 60.0133
CYS 70.0120
ILE 80.0281
LYS 90.0234
THR 100.0193
TYR 110.0189
SER 120.0121
LYS 130.0352
PRO 140.0265
PHE 150.0109
HIS 160.0180
PRO 170.0166
LYS 180.0220
PHE 190.0158
ILE 200.0077
LYS 210.0151
GLU 220.0128
LEU 230.0230
ARG 240.0316
VAL 250.0222
ILE 260.0228
GLU 270.0186
SER 280.0266
GLY 290.0287
PRO 300.0359
HIS 310.0224
CYS 320.0061
ALA 330.0095
ASN 340.0087
THR 350.0154
GLU 360.0162
ILE 370.0102
ILE 380.0141
VAL 390.0109
LYS 400.0102
LEU 410.0101
SER 420.0207
ASP 430.0500
GLY 440.0210
ARG 450.0458
GLU 460.0272
LEU 470.0178
CYS 480.0145
LEU 490.0121
ASP 500.0105
PRO 510.0269
LYS 520.0416
GLU 530.0187
ASN 540.0122
TRP 550.0311
VAL 560.0096
GLN 570.0084
ARG 580.0161
VAL 590.0170
VAL 600.0111
GLU 610.0209
LYS 620.0116
PHE 630.0086
LEU 640.0038
LYS 650.0490
ARG 660.0219
ALA 670.0193
GLU 680.0194
ASN 690.0412

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.